114 related articles for article (PubMed ID: 8420421)
1. Inhibition of platelet-activating factor-induced bronchoconstriction by the leukotriene D4 receptor antagonist ICI 204,219.
Kidney JC; Ridge SM; Chung KF; Barnes PJ
Am Rev Respir Dis; 1993 Jan; 147(1):215-7. PubMed ID: 8420421
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219.
Smith LJ; Geller S; Ebright L; Glass M; Thyrum PT
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):988-92. PubMed ID: 2158260
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of UK,74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans.
O'Connor BJ; Uden S; Carty TJ; Eskra JD; Barnes PJ; Chung KF
Am J Respir Crit Care Med; 1994 Jul; 150(1):35-40. PubMed ID: 8025768
[TBL] [Abstract][Full Text] [Related]
4. Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist.
Finnerty JP; Wood-Baker R; Thomson H; Holgate ST
Am Rev Respir Dis; 1992 Apr; 145(4 Pt 1):746-9. PubMed ID: 1554195
[TBL] [Abstract][Full Text] [Related]
5. Effects of inhaled leukotriene D4 and platelet-activating factor on airway reactivity in normal subjects.
Kaye MG; Smith LJ
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):993-7. PubMed ID: 2183659
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of platelet-activating factor induced bronchoconstriction by nedocromil sodium.
Hayes JP; Chung KF; Barnes PJ
Eur Respir J; 1992 Nov; 5(10):1193-6. PubMed ID: 1336735
[TBL] [Abstract][Full Text] [Related]
7. MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human.
Kips JC; Joos GF; De Lepeleire I; Margolskee DJ; Buntinx A; Pauwels RA; Van der Straeten ME
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):617-21. PubMed ID: 1892302
[TBL] [Abstract][Full Text] [Related]
8. Effect of cetirizine, a potent H1 antagonist, on platelet activating factor induced bronchoconstriction in asthma.
Ghosh SK; Rafferty P; De Vos C; Patel KR
Clin Exp Allergy; 1993 Jun; 23(6):524-7. PubMed ID: 8103703
[TBL] [Abstract][Full Text] [Related]
9. Failure of salmeterol to inhibit circulating white cell responses and bronchoconstriction induced by platelet activating factor.
Spring J; Johnston SR; Seale J; Ind PW
Thorax; 1992 Nov; 47(11):948-51. PubMed ID: 1361250
[TBL] [Abstract][Full Text] [Related]
10. Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction.
O'Shaughnessy KM; Taylor IK; O'Connor B; O'Connell F; Thomson H; Dollery CT
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1431-5. PubMed ID: 8389105
[TBL] [Abstract][Full Text] [Related]
11. Effect of a 5-lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on PAF-induced airway responses in neonatally immunized rabbits.
Herd CM; Donigi-Gale D; Shoupe TS; Page CP
Br J Pharmacol; 1992 Dec; 107(4):1108-15. PubMed ID: 1467833
[TBL] [Abstract][Full Text] [Related]
12. Participation of the cysteinyl leukotrienes in the acute bronchoconstrictor response to inhaled platelet activating factor in man.
Spencer DA; Evans JM; Green SE; Piper PJ; Costello JF
Thorax; 1991 Jun; 46(6):441-5. PubMed ID: 1858084
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of platelet activating factor-induced bronchoconstriction in humans.
Smith LJ; Rubin AH; Patterson R
Am Rev Respir Dis; 1988 May; 137(5):1015-9. PubMed ID: 3195800
[TBL] [Abstract][Full Text] [Related]
14. Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects.
Taylor IK; O'Shaughnessy KM; Fuller RW; Dollery CT
Lancet; 1991 Mar; 337(8743):690-4. PubMed ID: 1672176
[TBL] [Abstract][Full Text] [Related]
15. The effect of aerosolized SK&F 104353-Z2 on the bronchoconstrictor effect of leukotriene D4 in asthmatics.
Joos GF; Kips JC; Pauwels RA; Van der Straeten ME
Pulm Pharmacol; 1991; 4(1):37-42. PubMed ID: 1804493
[TBL] [Abstract][Full Text] [Related]
16. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers.
O'Shaughnessy TC; Georgiou P; Howland K; Dennis M; Compton CH; Barnes NC
Thorax; 1997 Jun; 52(6):519-22. PubMed ID: 9227717
[TBL] [Abstract][Full Text] [Related]
17. Effects of inhaled furosemide on platelet-activating factor challenge in mild asthma.
Echazarreta AL; Gómez FP; Ribas J; Achaval M; Barberà JA; Roca J; Chung KF; Rodriguez-Roisin R
Eur Respir J; 1999 Sep; 14(3):616-21. PubMed ID: 10543284
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.
Smith LJ; Glass M; Minkwitz MC
Clin Pharmacol Ther; 1993 Oct; 54(4):430-6. PubMed ID: 8222486
[TBL] [Abstract][Full Text] [Related]
19. [Effects of inhaled aerosol of platelet activating factor on pulmonary function and airway responsiveness in normal subjects].
Li Q
Zhonghua Jie He He Hu Xi Za Zhi; 1992 Aug; 15(4):222-4, 255. PubMed ID: 1307517
[TBL] [Abstract][Full Text] [Related]
20. The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma--A comparison with leukotriene D4 induced broncoconstriction.
Schelfhout V; Van De Velde V; Pauwels R; Joos G
Pulm Pharmacol Ther; 2008; 21(2):276-84. PubMed ID: 17611132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
